Neko Health
Neko Health is an Aging Diagnostics & Biomarkers company founded in 2018 and based in Stockholm, Sweden.
Neko Health was founded in 2018 by Hjalmar Nilsonne, its CEO, and Spotify co-founder Daniel Ek, and is headquartered in Stockholm, Sweden. It designs its own scanning hardware and software and runs clinics in Stockholm, London, Manchester and Birmingham. The Neko Body Scan takes about 60 minutes and uses proprietary sensors rather than radiation to map skin moles and measure blood pressure, heart rate and grip strength, while small blood samples processed on site cover cholesterol and blood sugar. A doctor reviews the results with the patient at the end of the visit. Customers pay per scan, priced at £299 in the UK. Neko raised a $260 million Series B led by Lightspeed Venture Partners in January 2025 at a $1.8 billion post-money valuation. On July 15, 2026 it announced a $700 million Series C led by Lightspeed with O.G. Venture Partners as co-lead, joined by General Catalyst, Atomico and Lakestar, and it is using the money to open US clinics, starting in New York.
Neko screens people without MRI or CT, combining sensors, on-site blood tests and a same-visit doctor review into a one-hour consumer scan. By July 2026 more than 100,000 people in Sweden and the UK had been scanned, 75% had booked and prepaid a follow-up, and its waitlist exceeded 350,000. Its $700 million Series C in July 2026 drew Lightspeed, O.G. Venture Partners, General Catalyst and Atomico and funds US clinics, starting in New York.
At a glance
Total raised
Undisclosed
Headcount
—
Headquarters
Stockholm
SwedenFounded
2018
Status
Private
Subsector
Where Neko Health ranks
Top 25 Longevity companies →Funding history
Total raised
—
Rounds tracked
1
Latest stage
Series C
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Jul 15, 2026 | Series C | $700M | — | Lightspeed Venture Partners, O.G. Venture Partners |